Therapeutic Grade HSA in a 25% solution is derived from human plasma. The plasma used to formulate this product has been tested by FDA approved methods and found to be non-reactive for HBsAg, anti-HIV1/2, anti-HCV, HIV-1 RNA, HCV RNA, and HBV DNA. Therapeutic Grade HSA is suitable for use as a culture media, diluent, or excipient.
For research use only. Not for use in diagnostic procedures.